HOME >> MEDICINE >> NEWS
Study shows surveillance could cut number of blood stream infections

A study from Imperial College London and Hammersmith Hospitals NHS Trust shows how a surveillance programme designed to monitor blood stream infections in dialysis units could cut the number of infections among patients.

The study, in the British Medical Journal, shows how the implementation of the surveillance scheme for patients undergoing haemodialysis significantly reduced the numbers of dialysis related blood stream infections, hospital admissions and the use of antibiotics.

The researchers found levels of bacteraemia (bacteria in the blood stream) fell from a rate of 6.2 percent of patients a month to 2.0 percent of patients a month over a two year period, a fall of almost 70 percent.

Dr Alison Holmes from Imperial College London, who led the research said: "The results from this study show we could have a nationwide way to effectively reduce the rates of blood stream infection and improve the quality of care in haemodialysis units through a simple and highly cost effective monitoring system. Despite surveillance being critical for monitoring infection control, no standardised surveillance scheme exists in the UK. We hope this study will encourage the creation of such a scheme."

Haemodialysis requires vascular access, either through the use of vascular catheters or through the creation of fistulas or grafts. These can all increase the risk of infection, but the use of catheters carry the greatest risk of blood stream infections.

The team of doctors and researchers introduced a US designed scheme to monitor patients undergoing dialysis at the Hammersmith Hospital haemodialysis unit, monitoring 3418 patient months of care between June 2002 and December 2004.

After setting up the scheme, and embedding it into the day to day activities of the unit, it took up approximately two hours per month of a dialysis physician's time.

They found that as well as reducing the numbers of access related infections, the sch
'"/>

Contact: Tony Stephenson
at.stephenson@imperial.ac.uk
44-207-594-6712
Imperial College London
19-Jun-2006


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... IN (PRWEB) , ... February 10, 2016 , ... ... benefits advisory organization, welcomes S.S. Nesbitt as the latest addition to its growing ... has seven other locations throughout the Southeast, from Orlando to Huntsville and in ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... the country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA ... volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the award-winning ... to physicians. The integration will enable Allscripts users to post open appointments to ... mobile app. , The partnership gives Everseat substantial added power to help Allscripts ...
(Date:2/10/2016)... ... ... Workrite Ergonomics this week announced the launch of the Conform Monitor Arm Series, ... was to develop a product from the ground up that would provide the most ... Hulsey, Product Manager for Workrite Ergonomics. “The Conform series features a wide variety ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... Immune Pharmaceuticals Inc. (NASDAQ: IMNP ), ... has filed a patent application directed to the treatment ... --> --> The new invention ... (histamine dihydrochloride) in combination with immune checkpoint inhibitors. The ... of Ceplene and IL-2 therapy in patients with Acute ...
(Date:2/10/2016)... ANGELES , Feb. 10, 2016  Oxis International ... cancer drug, OXS-1550, was described as a "clinical trial ... the drug went into complete cancer remission. ... University of Minnesota Masonic Cancer Center. --> ... University of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology:
Cached News: